Relationship of CD8+ T cell noncytotoxic anti-HIV response to CD4+ T cell number in untreated asymptomatic HIV-infected individuals

Blood

Volumn 99, Issue 11, 2002, Pages 4225-4227

  Castelli, JoAnn C ^a   Deeks, Steven G ^a   Shiboski, Stephen ^a   Levy, Jay A ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CLINICAL ARTICLE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; LEUKOCYTE COUNT; LYMPHOCYTE COUNT; MALE; MEDICAL DECISION MAKING; PATIENT MONITORING; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 0036624882     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2001-11-0078     Document Type: Article

References (14)

1. Carpenter CC, Cooper DA, Fischl MA, et al. Anti-retroviral therapy in adults: Updated recommendations of the International AIDS Society-USA Panel. JAMA. 2000;283:381-390.
2. Mackewicz CE, Yang LC, Lifson JD, Levy JA. Non-cytolytic CD8 T-cell anti-HIV responses in primary infection. Lancet. 1994;344:1671-1673.
3. + cell anti-HIV activity correlates with the clinical state of the infected individual. J Clin Invest. 1991;87:1462-1466.
4. + T lymphocyte control of HIV replication in cultured CD4+ cells varies among infected individuals. Cell Immunol. 1989;119:470-475.
5. Landay AL, Mackewicz C, Levy JA. An activated CD8+ T cell phenotype correlates with anti-HIV activity and asymptomatic clinical status. Clin Immunol Immunopathol. 1993;69:106-116,
6. Gomez AM, Smaill FM, Rosenthal KL. Inhibition of HIV replication by CD8+ T cells correlates with CD4 counts and clinical stage of disease. Clin Exp Immunol. 1994;97:68-75.
7. Levy JA, Mackewicz CE, Barker E. Controlling HIV pathogenesis: The role of noncytotoxic anti-HIV activity of CD8+ cells. Immunol Today. 1996;17:217-224.
8. Barker E, Mackewicz CE, Reyes-Teran G, et al. Virological and immunological features of long-term human immunodeficiency virus-infected individuals who have remained asymptomatic compared to those who have progressed to acquired immunodeficiency syndrome. Blood. 1998;92:3105-3114.
9. Matano T, Shibata R, Siemon C, et al. Administration of an anti-CD8 monoclonal antibody interferes with the clearance of chimeric simian/human immunodeficiency virus during primary infections of rhesus macaques. J Virol. 1998;72:164-169.
10. Schmitz JE, Kuroda MJ, Santra S, et al. Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes. Science. 1999;283:857-860.
11. Castro BA, Homsy J, Lennette E, at al. HIV-1 expression in chimpanzees can be activated by CD8+ cell depletion or CMV infection. Clinical Immunology and Immunopathology. 1992;65:227-233.
12. Cao Y, Ho DD, Todd J, et al. Clinical evaluation of branched DNA signal amplification for quantifying HIV type 1 in human plasma. AIDS Res Hum Retroviruses. 1995;11:353-361.
13. Levy JA, Shimabukuro J. Recovery of AIDS-associated retroviruses from patients with AIDS or AIDS-related conditions, and from clinically healthy individuals. J Infect Diseases. 1985;152:734-738.
14. Hoffman AD, Banapour B, Levy JA. Characterization of the AIDS-associated retrovirus reverse transcriptase and optimal conditions for its detection in virions. Virology. 1985;147:326-335.